Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation.
Yan L, Bui D, Li Y, Rajeevan N, Rowneki M, Berry K, Argraves S, Huang Y, Hynes DM, Cunningham F, Huang GD, Aslan M, Ioannou GN, Bajema KL.
Yan L, et al. Among authors: bui d.
Clin Infect Dis. 2024 Jun 12:ciae202. doi: 10.1093/cid/ciae202. Online ahead of print.
Clin Infect Dis. 2024.
PMID: 38864601